HOME > TOP STORIES
TOP STORIES
-
REGULATORY Daiichi Sankyo’s Enhertu, Novartis’ Beovu, Novo’s Ozempic OK’ed for Listing on May 20
May 13, 2020
-
REGULATORY Japan Regulators Upped Zolgensma Price after Novartis Complaints: Chuikyo Paper
May 13, 2020
-
REGULATORY Zolgensma to Get Japan’s Highest List Price 167 Million Yen, but Peak Sales Put at Just 4 Billion Yen
May 12, 2020
-
BUSINESS Amgen Boosting Repatha Supply System to Gear Up for Praluent Switches
May 11, 2020
-
BUSINESS Praluent Barred in Japan after Top Court Nixes Sanofi’s Patent Claim
May 8, 2020
-
REGULATORY Japan Approves Remdesivir as First Drug for COVID-19
May 8, 2020
-
REGULATORY Japan to Test Ivermectin for COVID-19: Prime Minister
May 7, 2020
-
BUSINESS Gilead Files Remdesivir for COVID-19 in Japan
May 4, 2020
-
REGULATORY Japan Likely to Take FDA’s Anticipated EUA as Cue for “Special” Remdesivir OK
May 1, 2020
-
BUSINESS Sanofi Japan to Ensure Drug Supplies, Employees’ Safety at the Same Time in COVID-19 Crisis: Chief
April 30, 2020
-
REGULATORY Japan Might Approve Gilead’s Remdesivir for COVID-19 in May
April 28, 2020
-
BUSINESS Novartis Japan Scraps Sales Offices to Boost Efficiency of Rep Activities
April 27, 2020
-
REGULATORY Japan Moving to Thwart Foreign Takeover of Drug, Medical Devices Makers
April 24, 2020
-
BUSINESS Gene Techno CEO Eyes Lucentis Biosimilar Launch in November 2021, Expects Share of “At Least 30%”
April 23, 2020
-
BUSINESS Japan Heading into Earnings Season amid Coronavirus Woes
April 22, 2020
-
BUSINESS Drug Makers Restricting Nafamostat Supplies as Hopes Grow for Its Repurposing for COVID-19
April 22, 2020
-
COMMENTARY Drug Rep Number Might Have Logged 5,000-Plus Decrease in 1 Year: Jiho Tally
April 22, 2020
-
BUSINESS Sawai Curbing Shipments for 2 More Drugs after Nichi-Iko’s Massive Recalls
April 21, 2020
-
BUSINESS Sumitomo Dainippon Chair Sees No Need for Further Consolidation among Japan Drug Makers
April 21, 2020
-
BUSINESS Some Drug Makers Rejuvenating Workforce by Boosting New Hires after Job Cuts: Jiho Survey
April 20, 2020
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
